NBIL: Advancing 3D bioprinting through innovation and strategy

Dell Technologies in association with YourStory presents Money Matters, a video series that unravels the financial strategies behind successful startups. We bring you inspiring stories of founders who’ve mastered the art of making money work smarter while building groundbreaking businesses.

In Episode 2, we spotlight Next Big Innovation Labs (NBIL), a trailblazer in 3D bioprinting technology. Led by co-founders Pooja Venkatesh, Piyush Padmanabhan, and Alok Medikepura, NBIL is reshaping the healthcare landscape by developing innovative bio-printing solutions for tissue engineering and regenerative medicine.

Their journey, fuelled by strategic grants and partnerships, highlights the power of meticulous R&D and market-driven innovation. From the first Made-in-India bioprinters to achieving international recognition with installations in South Korea, NBIL exemplifies how financial foresight and technology can drive scalable impact.

We speak to Pooja and Piyush to understand how NBIL balances resource-intensive R&D with profitability, ensuring their solutions remain accessible without compromising on quality or innovation.